Elon Musk's Neuralink has secured $650 million in Series E funding from prominent investors like ARK Invest and Sequoia Capital. This follows previous rounds totaling $280 million in 2023. The funding will support advances in brain chip technology, with clinical trials showing promising results—five individuals with severe paralysis have received brain chip implants. Additionally, Neuralink received breakthrough designation from the FDA, expediting its development process. The latest funding round values the company at about $9 billion, hinting at strong confidence from the investment community.
Elon Musk's brain computer interface startup Neuralink closed a $650 million funding round, which included notable investors like ARK Invest and Founders Fund.
Neuralink has made progress with its brain chip technology, having implanted chips in five individuals with severe paralysis in clinical trials.
The company received breakthrough device designation from the U.S. FDA, accelerating the development and review process for its innovative technologies.
This funding round values Neuralink at approximately $9 billion, reflecting investor confidence in its technological advancements.
Collection
[
|
...
]